Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.08 +0.06 (0.43%)
Previous Close $14.02    52 Week High $34.49 
Open $13.92    52 Week Low $20.39 
Day High $14.23    P/E N/A 
Day Low $13.45    EPS $-3.18 
Volume 233,451